A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2004
10/13/2004	EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004	EP1280820B1 Anti-inflammatory compounds and uses thereof
10/13/2004	EP1268472B1 3-aminopyrazole inhibitors of cyclin dependent kinases
10/13/2004	EP1261346A4 Modulation of cardiovascular injury
10/13/2004	EP1203014B1 Peptide antagonists of factor viia
10/13/2004	EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application
10/13/2004	EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity
10/13/2004	EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/13/2004	EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004	EP1053027B1 Bibapcitide-based pharmaceutical compositions for imaging and treating thrombi
10/13/2004	EP0934928B1 Cyclic amine derivatives
10/13/2004	CN1537167A Von willebrand factor (VWF)-cleaving enzyme
10/13/2004	CN1537111A Urea substituted imidazoquinolines
10/13/2004	CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004	CN1537099A Process for preparation of 3-spiro'cyclohexam-1, 3'-'3H indolin-2'-one derivatives
10/13/2004	CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor
10/13/2004	CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method
10/13/2004	CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists
10/13/2004	CN1536988A Sustained-release delivery system
10/13/2004	CN1536967A Nutritional composition preventing bacterial overgrowth
10/13/2004	CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative
10/13/2004	CN1535728A Drug composition for curing disease produced from IL-6
10/13/2004	CN1535700A Blood-supplementing medicine composition
10/13/2004	CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors
10/13/2004	CN1170827C Benzofurylpyrone deriuvatives
10/13/2004	CN1170592C New use of melagatran
10/13/2004	CN1170591C Pharmaceutical prepn. contg. fibrinolysin activators
10/13/2004	CN1170567C Ribes Janczewskii plant fruit extractive and its prepn
10/13/2004	CN1170558C Medicine for treating thrombocytopenia and its application in treating radiation disease
10/13/2004	CN1170546C Compound alum powder and its prepn
10/12/2004	US6803365 Imidazo[1,3,5]triazinones and the use thereof
10/12/2004	US6803363 Peritoneal dialysis solution with taurolidine
10/12/2004	US6803362 Heterocyclic compounds
10/12/2004	US6803212 Low oxygen affinity mutant hemoglobins
10/12/2004	US6803211 Cancer therapy
10/12/2004	US6803038 Stimulating plasmin production; inhibiting fibrin production and adhesion of human thrombocytes on endothelilum cells
10/12/2004	CA1341458C Modified human t-pa
10/07/2004	WO2004060362B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
10/07/2004	WO2003099195A3 Immunomodulatory compounds and methods of use thereof
10/07/2004	WO2003068757A9 Novel pyridin- and pyrimidin-derivatives
10/07/2004	WO2003068748A9 Novel pyridine- and quinoline-derivatives
10/07/2004	US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders
10/07/2004	US20040198832 Compositions and methods for treating amyloidosis
10/07/2004	US20040198787 Efficient process for the preparation of a factor Xa inhibitor
10/07/2004	US20040198781 Carbonic anhydrase inhibitor
10/07/2004	US20040198766 Chemical compounds
10/07/2004	US20040198759 Aporphine and oxoaporphine compounds and pharmaceutical use thereof
10/07/2004	US20040198749 Methods of using sodium channel blockers
10/07/2004	US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders
10/07/2004	US20040198747 Sodium channel blockers
10/07/2004	US20040198746 Sodium channel blockers
10/07/2004	US20040198745 Sodium channel blockers
10/07/2004	US20040198744 Methods of using phenolic guanidine sodium channel blockers
10/07/2004	US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
10/07/2004	US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors
10/07/2004	US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders
10/07/2004	US20040198692 C-pyrazole A2A receptor agonists
10/07/2004	US20040198658 Stanniocalcin polynucleotides, polypeptides and methods based thereon
10/07/2004	US20040198651 Secreted proteins
10/07/2004	US20040197875 in which the B-domain is partially or completely deleted and may be replaced by a DNA linker segment; for use in human gene therapy
10/07/2004	US20040197427 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same
10/07/2004	US20040197409 a prosthetic device (sleeve) placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material; flexible, cylindrical, bioabsorbing, agent-eluting matrix with a vascular-sized lumen
10/07/2004	US20040197404 Extended release oral dosage form
10/07/2004	US20040197390 Mixture of expression vector for antihemophilic factor and lipid; delivering of DNA expression vehicle encoding Factor VIII to a cell
10/07/2004	US20040197345 Prostate derived Ets factor
10/07/2004	US20040197337 Methods to impair hematologic cancer progenitor cells and compounds related thereto
10/07/2004	US20040197307 Mixture of human interferons
10/07/2004	DE202004010172U1 Composition for treating hemorrhoids comprises unsalted lard and selected dried herbs
10/06/2004	EP1464673A2 Polyanhydrides with biologically active degradation products
10/06/2004	EP1464330A1 Use of a composition containing oligosaccharides in combination with a saponine or a basic aminoacid, for topical administration or for inhalation
10/06/2004	EP1463823A2 Methods of increasing endogenous erythropoietin (epo)
10/06/2004	EP1463820A1 Method of screening compounds
10/06/2004	EP1463803A2 Hematopoietic cells from human embryonic stem cells
10/06/2004	EP1463799A2 Methods for the induction of professional and cytokine-producing regulatory cells
10/06/2004	EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
10/06/2004	EP1463758A2 Mammal prolactin variants
10/06/2004	EP1463756A2 Secreted proteins
10/06/2004	EP1463751A2 Albumin fusion proteins
10/06/2004	EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use
10/06/2004	EP1463524A2 METHODS OF THERAPY FOR NON−HODGKIN S LYMPHOMA
10/06/2004	EP1463412A2 Composition comprising wenguanguo extracts, methods for preparing same and uses therof
10/06/2004	EP1379262B1 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
10/06/2004	EP1296981B1 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/06/2004	EP1263300B1 Improvements in or relating to solubilisation of flavonols
10/06/2004	EP1248787B1 NOVEL SUBTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM
10/06/2004	EP1210325B1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha
10/06/2004	EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents
10/06/2004	EP1064270B1 Disubstituted pyrazolines and triazolines as factor xa inhibitors
10/06/2004	EP1019096B1 Bioresorbable compositions for implantable prostheses
10/06/2004	EP1018878B1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
10/06/2004	EP0975340B1 Therapeutic inhibitor of vascular smooth muscle cells
10/06/2004	CN1534094A Recombination protein for dissolving thrombus and its engineering bacteria
10/06/2004	CN1533798A Chinese medicinal composition for preventing and treating anemia
10/06/2004	CN1169834C Process for separating megakaryocyte stimulating factor from human plasma and application
10/06/2004	CN1169532C Liquor for treating rheumatism and arthritis
10/05/2004	US6800659 Compounds for modulating cell proliferation
10/05/2004	US6800654 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
10/05/2004	US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance.
10/05/2004	US6800627 Central nervous system, cardiovascular and gastrointestinal disorders, diabetes inspidus, sleep apnea
10/05/2004	US6800626 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.

1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 671